Autologous Growth Factor-Rich Concentrate (GFC) Injection in Non-union of Fractures: A Quasi-experimental Study
In brief
In this quasi-experimental study without a control group, patients with long-bone fractures that had failed to unite received a series of growth factor concentrate (GFC) injections at the fracture site. No side effects were recorded and most showed better bone healing on X-ray; the authors describe the approach as safe and potentially useful but call for randomised trials.
Read the original paper (opens in a new tab)
Citation, as listed in the PRP guidelines
Autologous Growth Factor-Rich Concentrate (GFC) Injection in Non-union of Fractures: A Quasi-experimental Study Authors: Karun Jain, Madhan Jeyaraman, Naveen Jeyaraman & Ashim Gupta Link: https://link.springer.com/article/10.1007/s43465-024-01278-1 Year of Publication: 2024
A summary of published research for general information. It does not replace a consultation; whether a treatment suits you is decided by a specialist after examination.
More from the PRP guidelines
- Autologous Peripheral Blood-Derived Orthobiologics for the Management of Elbow Disorders: A Review of Current Clinical Evidence2025
- Intra-articular injections of hyaluronic acid versus plasma rich in growth factors (PRGF) for knee osteoarthritis: a meta-analysis of randomised controlled trials2025
- Comparison of Platelet-Rich Plasma and Corticosteroid Injections for Chronic Plantar Fasciitis: A Randomized Controlled Trial2024
- The Safety and Effectiveness of Orthobiologic Injections for Discogenic Chronic Low Back Pain: A Multicenter Prospective, Crossover, Randomized Controlled Trial with 12 Months Follow-up2024

